HomeVTGN • NASDAQ
add
Vistagen Therapeutics Inc
Previous close
$2.05
Day range
$2.08 - $2.17
Year range
$1.90 - $4.96
Market cap
62.78M USD
Avg Volume
123.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 234.00K | -43.07% |
Operating expense | 15.35M | 85.10% |
Net income | -14.09M | -121.87% |
Net profit margin | -6.02K | -289.70% |
Earnings per share | -0.46 | -109.09% |
EBITDA | -15.08M | -92.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 88.56M | -30.02% |
Total assets | 92.31M | -29.57% |
Total liabilities | 11.18M | 43.71% |
Total equity | 81.12M | — |
Shares outstanding | 28.86M | — |
Price to book | 0.72 | — |
Return on assets | -38.81% | — |
Return on capital | -42.57% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -14.09M | -121.87% |
Cash from operations | -10.28M | -116.56% |
Cash from investing | -422.00K | -1,218.75% |
Cash from financing | 1.17M | -98.75% |
Net change in cash | -9.53M | -110.71% |
Free cash flow | -5.20M | -64.66% |
About
Founded
1998
Headquarters
Website
Employees
48